Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...

As we age, neurocognitive disorders, including dementia and Alzheimer’s disease, can be particularly worrisome, impacting not just the individual but also their loved ones. Understanding the ...

A new European consensus statement offers expert guidance on which biomarkers to use for patients presenting with cognitive complaints. Led by Giovanni B. Frisoni, MD, Laboratory of Neuroimaging of ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...

Michael Hornberger does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...